Early Data Encouraging for Development of Blood-Based MicroRNA Test for Germ Cell Cancers | GenomeWeb

NEW YORK (GenomeWeb) – Researchers from the University of Cambridge have published new data that they hope will lead to the development of a clinical test that utilizes four blood-borne microRNAs to detect the presence of germ cell cancers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.